ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

Lower But More Frequent Dose Rituximab to Treat Chronic Lymphocytic Leukemia

National Heart, Lung, and Blood Institute (NHLBI) · 2006
ClinicalTrials.gov · Datasets · License: Public Domain · 2006
Open Source ↗
refractory chronic lymphocytic leukemia, cll, monoclonal antibody therapy, anti cd20, biologic response modifier therapy, fractionated-dose, low-dose, chronic lymphocytic leukemia, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 811687
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.